renal cell carcinoma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

renal cell carcinoma
May 6, 2025, 11:41 | Opinion
Diego A Díaz García: ICIs Have Changed the Game in Renal Cell Carcinoma, but Predictive Tools Lag Behind
Diego A Díaz García, Medical Oncologist /CEO/Founder at CánCare – High Specialty in Oncology, shared…
Apr 7, 2025, 08:29 | Blog
Sergio Cifuentes Canaval: Results of SBRT for Primary RCC in a Large Multicenter Series
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, posted on X: "Results of…
Apr 1, 2025, 09:47 | Science
Giulia Claire Giudice: Strategies for RCC patients progressing on ICIs
Giulia Claire Giudice, Medical Doctor at University Hospital of Parma, shared an article on X: "Newly…
Mar 30, 2025, 14:45 | Science
Daniela Castro: Impact of insurance status on survival outcomes in patients with mRCC
Daniela Castro, Clinical Research Associate of Medical Oncology at City of Hope, shared a post…
Mar 24, 2025, 02:33 | Cancer Types
Kidney Cancer: Symptoms ,Causes, Stages, Diagnosis and Treatment
Kidney cancer, also known as renal cancer, originates in the kidneys—two bean-shaped organs located on…
Mar 17, 2025, 10:05 | Blog
March is Kidney Cancer Awareness Month
OncoDaily joins the global community in raising awareness about kidney cancer, a disease that affects…
Mar 3, 2025, 12:13 | Science
Samuel Hume: Top 5 advances in medicine in February
Samuel Hume, Fellow at The Foulkes Foundation and pursuing PhD in the University of Oxford’s…
Mar 2, 2025, 13:57 | Science
Mohammad Jad Moussa: Nivolumab plus ipilimumab in metastatic variant histology renal cell carcinoma
Mohammad Jad Moussa, Oncology Fellow at MD Anderson Cancer Center, shared a post on X…
Feb 26, 2025, 11:10 | Blog
Andrea Necchi: A Clinical Gene Therapy Study with Hematopoietic Stem Cells for the Treatment of RCC
Andrea Necchi, Head of Genitourinary Medical Oncology at Ospedale San RaffaeleOspedale, shared a post on…
Feb 25, 2025, 09:48 | Science
Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21
Dana-Farber Lank Center for Genitourinary Oncology shared a post on X: "GU Research Digest for…
Feb 25, 2025, 09:17 | Science
Lena Wirth: TLS and T-Cell Exhaustion Drive PD-1 Blockade Responce in RCC
Lena Wirth, Immunobiology Graduate Student at Yale University, shared a post on X about a…
Feb 25, 2025, 07:58 | Science
Efficacy and safety of nivo/ipi in patients with metastatic vhRCC by Mohammad Jad Moussa et al.
A paper by Mohammad Jad Moussa et al. was published in Journal for ImmunoTherapy of…
Feb 17, 2025, 08:07 | Science
Marco Donia: Personalized Cancer Vaccines in Renal Cell Carcinoma - Phase I Study
Marco Donia, Associate Professor in Clinical Oncology at the University of Copenhagen, shared an article…
Feb 13, 2025, 08:52 | Science
Gustavo Viani: SBRT vs. ablation for kidney cancer - a game-changer?
Gustavo Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, shared a post on…
Feb 13, 2025, 07:41 | Science
Yüksel Ürün: SBRT, A powerful option for inoperable RCC
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by…
Feb 12, 2025, 15:01 | Science
Bibi Maryam: The prognostic role of ctDNA clearance in localized and metastatic RCC
Bibi Maryam, Resident Physician at University of Oklahoma, shared an article by Adanma Ayanambakkam, et…
Feb 12, 2025, 07:01 | Science
Yousef Zakharia: IIT in recur refractory RCC
Yousef Zakharia, Associate Professor of Medicine at The University of Iowa, shared his recent articles…
Feb 12, 2025, 06:20 | Science
Miguel Bronchud: Good news for the commonest clinical kidney cancer
Miguel Bronchud, Co-Founder & Advisory Board at Regenerative Medicine Solutions, shared an article on LinkedIn:…
Feb 11, 2025, 15:01 | Science
Hatice Bölek: Sunitinib in metastatic renal cell carcinoma
Hatice Bölek, Medical Oncologist at Ankara University School of Medicine, shared her recent article on…
Feb 11, 2025, 10:56 | Blog
Enrique Grande: Meta-analysis compares ablative therapies for localized renal cell carcinoma
Enrique Grande, Head of Oncology at MD Anderson Cancer Center, shared on LinkedIn about recent…
Feb 10, 2025, 16:45 | Science
Patrick Hwu: The potential of personalized cancer vaccines as an effective adjuvant therapy in RCC
Patrick Hwu, President and CEO of Moffitt Cancer Center, shared a post on LinkedIn about…
Feb 10, 2025, 15:21 | Science
Erman Akkus: Our study on SGLT2 and papillary RCC
Erman Akkus, Medical Oncology Fellow at Ankara University, shared an article on X: "Our study…
Feb 8, 2025, 07:34 | Science
Ciro Franzese: An international multicenter study of stereotactic radiotherapy for renal cell carcinoma
Ciro Franzese, Associate Professor in Radiation Oncology at Humanitas University, shared on LinkedIn:  "Joining forces…
Feb 8, 2025, 07:09 | Science
Srinivas Viswanathan: TFE3 fusion drives a key oxidative phosphorylation in translocation RCC
Srinivas Viswanathan, Principal Investigator at Dana-Farber Cancer Institute and an Assistant Professor at Harvard Medical…
Feb 8, 2025, 06:51 | Science
Emre Yekedüz: A new era has started in the treatment of kidney cancer
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, shared an article by David A.…
Feb 7, 2025, 13:19 | Blog
Yasser Mohamed Ali Ged: IO Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma
Yasser Mohamed Ali Ged, GU Medical Oncologist at Johns Hopkins Kimmel Cancer Center, shared on…
Feb 5, 2025, 17:53 | Science
Akhil Santhosh: Adjuvant immunotherapy trials in resected RCC
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, posted on X:…
Jan 30, 2025, 06:00 | Insight
Advancing insights in metastatic renal cell carcinoma - International Urology Cancer Summit
International Urology Cancer Summit shared a post on LinkedIn about a recent paper by "…
Jan 20, 2025, 13:23 | Blog
Riccardo Campi: Our first Florence Multidisciplinary Expert Meeting on RCC
Riccardo Campi, Chairman of EAU-YAU Renal Cancer Working Group and Urologist at Careggi University Hospital…
Jan 19, 2025, 07:45 | Science
Cristiane Bergerot: Mindfulness via smartphone
Cristiane Bergerot, Director of the Department of Psycho-Oncology at CETTRO Cancer Research Hospital, shared a…
Jan 18, 2025, 22:52 | Blog
Yüksel Ürün: Florence Multidisciplinary Expert Meeting on Renal Cell Carcinoma
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine in Turkey, shared a…
Jan 12, 2025, 16:35 | Science
Pavlos Msaouel: Sitravatinib with nivolumab and ipilimumab in advanced clear cell renal cell carcinoma
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, posted on…
Dec 27, 2024, 16:33 | Science
Longitudinal monitoring of Circulating Tumor DNA dynamics in metastatic RCC - International Urology Cancer Summit
International Urology Cancer Summit shared a recent article by Arnab Basu on X: "Longitudinal monitoring…
Dec 19, 2024, 02:31 | Science
Laura Bukavina: Use of Perioperative Immunotherapy and TKI in RCC with IVC thrombus patients by Kotaro Suzuki et al.
A recent paper by Kotaro Suzuki, Postdoctoral Research Fellow at Vancouver Prostate Centre of the…
Dec 16, 2024, 16:21 | Blog
Professors Hailiang Zhang and Xiaolin Lu’s Team Unveils Multi-Omics Insights into TRCC - Mediamedic
Mediamedic shared a post on LinkedIn: "Editor’s Note: Translocation renal cell carcinoma (TRCC), though rare,…
Dec 15, 2024, 11:04 | Science
Real-world outcomes of Cabozantinib in advanced renal cell carcinoma (CASSIOPE Study)
Dra. María Natalia Gandur Quiroga, Coordinator in charge of the Urology Clinic Service at the…
Dec 12, 2024, 09:43 | Insight
Giuseppe Procopio: Results of the prospective multicenter Cassiope trial in renal cell carcinoma
Giuseppe Procopio, Director of the Genitourinary cancer Unit at National Cancer Institute Foundation, shared on…
Dec 7, 2024, 01:42 | Blog
Toni Choueiri: Excited to share the results of FRACTION-RCC
Toni Choueiri, the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer…
Nov 12, 2024, 18:05 | Blog
Markus Eckstein: Have you ever heard about SDHB deficient renal cell carcinoma?
Markus Eckstein, Senior Physician/Pathologist and Clinician Scientist at the University Hospital Erlangen, shared a post…
Nov 12, 2024, 18:01 | Blog
Sitravatinib/Ipi/Niv as first line treatment for advanced RCC
Qian Janie Qin, Assistant Professor at UT Southwestern Medical Center, shared a recent article by…
Nov 12, 2024, 09:20 | Insight
Sounak Gupta: mRCC with Fibromyomatous Stroma associated with Tuberous Sclerosis
Sounak Gupta, Pathologist at Mayo Clinic, shared a post on X about his recent paper…
Nov 11, 2024, 17:49 | Blog
Erman Akkus: Nivolumab-ipilimumab vs SOC for non-clear cell RCC
Erman Akkus, Medical Oncology fellow at the Ankara University, shared a post on X: "Nivolumab-ipilimumab…
Nov 8, 2024, 17:48 | Blog
Molecular Analysis of Renal Cell Carcinoma Sites
Enrique Grande, Head of Oncology at MD Anderson Cancer Center Madrid, shared an article by…
Nov 7, 2024, 15:29 | Insight
Angelo D'Alessandro: New mechanism of protection from cuproptosis in cRCC
Angelo D'Alessandro, Professor at the University of Colorado Anschutz Medical Campus, shared on X: “Now…
Nov 3, 2024, 12:51 | Insight
Will the future of papillary renal cell carcinoma research offer tricks, or treats?
Uromigos shared a post on X: “Will the future of papillary RCC research offer tricks,…
Oct 28, 2024, 09:55 | Blog
Anh Lam: Spontaneous regression of Renal Cell Carcinoma
Anh Lam, IM Resident, OU Health, shared a post on X: "I’m very proud to get…
Oct 28, 2024, 09:40 | Blog
Nicholas Zaorsky: Protecting kidney function after local renal cell carcinoma therapy
Nicholas Zaorsky, Associate Professor, Case Western Reserve University, shared a post on X: "Protecting kidney function…
Oct 26, 2024, 15:56 | Blog
Shikha Gupta: CDK4/6 inhibitors as a promising therapeutic approach in translocation RCC
Shikha Gupta, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Excited to…
Oct 20, 2024, 18:54 | Insight
UCLA: New imaging technique accurately detects aggressive kidney cancer
UCLA investigators found the level of accuracy of the non-invasive method could lead to earlier…
Oct 1, 2024, 14:10 | Blog,Opinion
Yüksel Ürün: Congratulations to Aruni Ghose and team for winning the Best Poster Award
Aruni Ghose shared a post by Yüksel Ürün, on X: ''Meet URO Italy to International…
Sep 29, 2024, 09:49 | Blog
Adjuvant Everolimus in Patients with Completely Resected, High-risk Renal Cell Carcinoma - European Urology
European Urology shared on X: "Platinum Priority - Kidney Cancer: Adjuvant Everolimus in Patients with…
Sep 24, 2024, 08:46 | Blog
Sarah Scagliarini: The Top 10 Italian Priorities in RCC
Sarah Scagliarini shared a post on LinkedIn: "Save The Date!!! The Top 10 Italian Priorities…
Sep 23, 2024, 13:54 | Career
Daniel J. George Received KCA’s Nicholas J. Vogelzang Humanitarian Award
Daniel J. George recently received the KCA’s Nicholas J Vogelzang Humanitarian Award. Dr. George serves…
Sep 17, 2024, 10:19 | Insight
Renee Maria Saliby: Is ICI-rechallenge the right thing to do in renal cell carcinoma?
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on X:…
Sep 14, 2024, 13:44 | Societies
Neeraj Agarwal's highlights from ESMO24
The ESMO Congress 2024 (ESMO24) is one of the most globally influential platforms in oncology,…
Sep 14, 2024, 11:04 | Blog
Dr. Andrea Apolo's highlights from ESMO24 - Day 1
24th European Society for Medical Oncology (ESMO) Congress, a major event in the field of…
Sep 3, 2024, 14:47 | Insight
Article of the day, September 3rd, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 2, 2024, 14:30 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Aug 24, 2024, 06:53 | Insight
Srinivas Viswanathan: A genetic basis for sex differences in Xp11 translocation renal cell carcinoma
Recently, an article by Srinivas Viswanathan et al. titled "A genetic basis for sex differences in…
Aug 19, 2024, 12:16 | Insight
Talal El Zarif: After adjuvant immunotherapy, what comes next in renal cell carcinoma?
Talal El Zarif shared a post by Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber…
Aug 17, 2024, 08:50 | Insight
Karl Semaan: Our study on first-line systemic therapy after adjuvant immunotherapy in RCC
Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on X…
Aug 16, 2024, 14:16 | Insight
Karl Semaan: First-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma
Karl Semaan, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “Just…
Aug 7, 2024, 01:22 | Insight
8 years of follow-up in the CheckMate 214 trial
Yüksel Ürün shared a paper by Nizar M. Tannir et al. on X: "Nivolumab +…
Aug 4, 2024, 17:24 | Blog
Neeraj Agarwal: Liquid epigenomic profiling to diagnose RCC patients with residual disease surgery
Neeraj Agarwal shared on X: "Another stellar talk by David Braun in World GU Conference…
Aug 1, 2024, 06:56 | Blog
Radiologic assessment before first line therapy for mccRCC
Cancer Network shared a post on X: ''Radiological tumor burden, if shown to have a…
Jul 28, 2024, 08:32 | Blog
At ANZUP 24 Cristiane Bergerot presented a new HRQOL measure for patients with localized and metastatic RCC - Florez Lab
Florez Lab shared on X: "At ANZUP 24 Dr. Cristiane Bergerot presented a new HRQOL…
Jul 27, 2024, 03:08 | Insight
Liang Cheng: Comprehensive resource on AI applications for prostate cancer management
Liang Cheng, Director of Anatomic Pathology and Molecular Pathology at Warren Alpert Medical School of…
Jul 24, 2024, 00:59 | Blog
Paulo Bergerot: Our first study on Exercise Oncology for patients with RCC
Paulo Bergerot, Medical Oncologist at Oncoclínicas Group, shared a post on X: "Yeah! Our first…
Jul 16, 2024, 20:13 | Insight
Chinmay Jani: Truly honored to receive the Merit Award
Chinmay Jani, Clinical Fellow, Hematology and Oncology at University of Miami, made the following post…
Jul 15, 2024, 11:30 | Blog
Neeraj Agarwal: Excellent talk by Michelle Hirsch on the pathology diagnosis of RCC variants
Neeraj Agarwal shared on X: "Surgical Pathology Toolbox and Technological Advances to Solve Kidney Cancer…
Jul 7, 2024, 14:42 | Blog
Sweta Agrawal: Key Takeaways from Support Group Meeting held for RCC at Patan Hospital in Lalitpur
Sweta Agrawal, Program Coordinator Nepal at The Max Foundation, made the following post on LinkedIn:…
Jul 6, 2024, 08:45 | Insight
Tom Powles on RCC patients receiving ICI therapy
Tom Powles shared on X: “During the period of PD-1 inhibition availability for RCC in…
Jul 4, 2024, 10:51 | Blog
Toni Choueiri: Some major changes for systemic therapies in the updated NCCN guidelines are in
Toni Choueiri shared a post on X: "Updated National Comprehensive Cancer Network (NCCN) guidelines (1.2025)…
Jul 1, 2024, 23:51 | Insight
Piotr Wysocki: Neoadjuvant therapy for renal-cell cancer patients is still in its infancy, unlike in melanoma
Piotr Wysocki recently posted on LinkedIn: "The PROSPER ECOG-ACRIN EA8143 study (published online in Lancet…
Jun 24, 2024, 17:45 | Blog
The Max Foundation offers three medications for RCC
Sudha Samineni, Program Officer at The Max Foundation, shared on LinkedIn:         …
Jun 20, 2024, 14:10 | Insight
Enrique Grande: Epigenomic signatures of sarcomatoid differentiation of RCC
Enrique Grande shared a post on X: "On Cell Reports - Epigenomic signatures of sarcomatoid…
Jun 19, 2024, 12:33 | Blog
Maria Babak: How Bevacizumab is revolutionizing treatment for multiple cancers
Maria Babak shared a post by CityU iGEM on LinkedIn: "Discover how Bevacizumab, a powerful cancer…
Jun 3, 2024, 15:09 | Insight
Avelumab + Axitinib Did Not Improve Overall Survival in Patients with Metastatic Renal Cell Carcinoma: Don't Panic!
"Final overall survival (OS) and progression-free survival (PFS) results for patients with metastatic clear cell…
May 25, 2024, 10:11 | Insight
Excellent review by Albert Jang and Shilpa Gupta on papillary RCC - Kidney Cancer Journal
Kidney Cancer Journal shared on X: "Just in Kidney Cancer Journal Excellent review by Albert…
May 23, 2024, 13:10 | Societies
Updated ESMO Clinical Practice Guideline on Renal Cell Carcinoma - ESMO
ESMO – European Society for Medical Oncology posted on LinkedIn: “Updated Renal Cell Carcinoma: ESMO…
May 23, 2024, 06:36 | Insight
María Natalia Gandur Quiroga: New insights on immunotherapy rechallenge in mRCC
María Natalia Gandur Quiroga shared on X: "New insights on immunotherapy rechallenge in mRCC! Key…
May 19, 2024, 10:12 | Insight
Erman Akkus: Is oncologic treatment of very advanced disease associated with improved survival?
Erman Akkus, Medical Oncology Fellow at Ankara University shared a post on X: “Is oncologic treatment…
May 17, 2024, 17:18 | Cancer Types
Renal Cell Carcinoma in Children: What patients and caregivers should know about
What is Renal Cell Carcinoma? Renal cell carcinoma (RCC) is a rare type of kidney…
May 17, 2024, 16:25 | Cancer Types
Renal Cell Carcinoma in Adults: What patients should know about
What is renal cell carcinoma? Renal cell carcinoma (RCC), also known as renal cell cancer…
May 15, 2024, 12:22 | Blog
The Babak Lab - Exciting Progress in Melanoma Treatment: Personalized Vaccines Show Promise
Maria Babak, Head of Drug Discovery Lab at City University of Hong Kong, shared a post…
May 12, 2024, 07:40 | Insight
Yüksel Ürün: Excellent research on plasma Kidney Injury Molecule-1
Yüksel Ürün shared on X: "Congratulations to Wenxin Xu and the team for their excellent…
May 1, 2024, 11:48 | Insight
Chadi Chehade: Happy to share our editorial recently published in Cancer Cell!
Chadi Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, shared a post by Neeraj Agarwal…
Apr 30, 2024, 11:10 | Blog
Mohammad Jad Moussa: Proud of Stefan Maksimović, finalist for tripartite 'Lawrence Family Bone Disease Prog of Texas' Awards
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared on…
Apr 24, 2024, 21:07 | Blog
Olubukola Ayodele: I had the pleasure of meeting with Daniel Heng, the creator of the IMDC prognostic risk criteria for aRCC
Olubukola Ayodele, Consultant Medical Oncologist at University Hospitals of Leicester Cancer Research Centre, shared a…
Apr 23, 2024, 16:11 | Blog
Laura Bukavina: Congrats on the award for top poster at IKCSEU24
Laura Bukavina, Assistant Professor of Urologic Oncology at Case Western Reserve University, shared on X:…
Apr 20, 2024, 06:03 | Insight
Toni Choueiri: The long-awaited OS results from KEYNOTE-564 are out at the New England Journal of Medicine!
Toni Choueiri shared on X/Twitter: "The long-awaited OS results from KEYNOTE-564 are out at the New…
Apr 16, 2024, 13:08 | Blog
Shilpa Gupta: Great to have Yousef Zakharia, UI Holden Comprehensive Cancer Center talk about updates in kidney cancer
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared a post on X/Twitter: ''Great…
Apr 11, 2024, 12:10 | Blog
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma, by Sumanta K. Pal et al - Cancer Discovery
Cancer Discovery shared on X/Twitter: "Just published with the AACR24 Clinical Plenary presentation: CD70-Targeted Allogeneic CAR…
Apr 8, 2024, 22:02 | Insight
Renee Maria Saliby: Our paper 'Impact of RCC molecular subtypes on immunotherapy and targeted therapy outcomes' is now published in Cancer Cell
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Feb 2, 2024, 17:33 | Drugs
Day 3 of GU24 ASCO Highlights by Oncology Brothers
Oncology Brothers recently tweeted: "Day 3 of GU24 ASCO Highlights 1. KN564: Adj Pembro w/…
Jan 29, 2024, 17:43 | Insight
Minas Economides: First positive OS trial in adjuvant RCC
Minas Economides, GU Medical Oncologist and Assistant Professor of Medicine at NYU Langone Health, shared…
Jan 18, 2024, 16:11 | Insight
Erman Akkus: GIMs should be suspected in case of anemia or GI bleeding in patient with a history of RCC
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Gastrointestinal metastasis (GIM) of…
Jan 16, 2024, 01:08 | Blog
Renee Maria Saliby: Always grateful and fortunate to have David Braun's guidance
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, made the following…
Nov 29, 2023, 17:00 | Insight
Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
Maite Bourlon, Urology Oncologist at the National Institute of Medical Sciences and Nutrition Salvador Zubirán,…
Oct 3, 2023, 18:20 | Insight
Shankar Siva: Thank you patients, families, trial staff and investigators for participating in TROG (Trans Tasman Radiation Oncology Group) Cancer Research 15.03 FASTRACK II!
12
All: 103 Posts: 1 - 100
Special Coverage